Small Pharma Inc

Company Profile

Small Pharma Inc had its IPO on under the ticker symbol DMTTF.

The company operates in the Healthcare sector and Biotechnology industry. Small Pharma Inc has a staff strength of 0 employees.

Stock update

Shares of Small Pharma Inc opened at $0.07 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.07 - $0.07, and closed at $0.07.

This is a +3.92% increase from the previous day's closing price.

A total volume of 24,830 shares were traded at the close of the day’s session.

In the last one week, shares of Small Pharma Inc have increased by +6.88%.

Small Pharma Inc's Key Ratios

Small Pharma Inc has a market cap of $16.88 million, indicating a price to book ratio of 1.1466 and a price to sales ratio of 69845.664.

In the last 12-months Small Pharma Inc’s revenue was $-1162 with a gross profit of $45000 and an EBITDA of $-24275440. The EBITDA ratio measures Small Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Small Pharma Inc’s operating margin was 0% while its return on assets stood at -41.24% with a return of equity of -78.26%.

In Q3.6666666666667, Small Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Small Pharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Small Pharma Inc’s profitability.

Small Pharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.0556. Its price to sales ratio in the trailing 12-months stood at 69845.664.

Small Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$25.02 million

Total Liabilities

$6.08 million

Operating Cash Flow

$0

Capital Expenditure

$2410

Dividend Payout Ratio

0%

Small Pharma Inc ended 2024 with $25.02 million in total assets and $0 in total liabilities. Its intangible assets were valued at $25.02 million while shareholder equity stood at $18.94 million.

Small Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $6.08 million in other current liabilities, in common stock, $-52267986.00 in retained earnings and $0 in goodwill. Its cash balance stood at $22.74 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Small Pharma Inc’s total current assets stands at $24.97 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $844275.00 compared to accounts payable of $0 and inventory worth $0.

In 2024, Small Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $2410.

Comparatively, Small Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.07

52-Week High

$0.3328

52-Week Low

$0.0465

Analyst Target Price

$

Small Pharma Inc stock is currently trading at $0.07 per share. It touched a 52-week high of $0.3328 and a 52-week low of $0.3328. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.06 and 200-day moving average was $0.06 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3108.1% of the company’s stock are held by insiders while 305.4% are held by institutions.